Cell Therapy Technologies Market Size, Share, Growth Analysis, By Technology(Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology), By Use(Clinical Use), By Cell(Stem Cell Therapies, BM, Blood, & Umbilical Cord-derived Stem Cells), By Therapy(Allogenic Therapies, Autologous Therapies), By Product(Consumables, Equipment, Systems, and Software), By Therapeutic Area(Oncology, Musculoskeletal Diseases), By Region - Industry Forecast 2024-2031

North America accounted for the largest revenue share of 58.7% in 2023. This is due to collaboration between research institutes and major pharmaceutical companies. Growth is coming through several joint ventures in this area. For example, in June 2022, Ematics partnered with Bristol Myers Squibb to develop the Gamma Delta Allogenic Cell Therapy Programs. The United States is a leading player in the global cell therapy technology market. It emphasizes the research, development, and development of cell therapies, particularly in cancer, cardiology, and neuroscience in the US. The regulatory environment is supportive of new cell therapies, and the country has a variety of services and research institutes.

Asia-Pacific is estimated to register the highest CAGR during the forecast period owing to the high demand for cellular therapies in the region. Factors such as increasing awareness of alternative therapies, increasing investments, and better policy expectations from governments are estimated to accelerate market growth during the forecast period. China’s cell therapy market is growing rapidly, driven by technical services and consulting. The market is characterized by a focus on innovation and digital transformation in line with China’s ambitions in electric vehicles and renewable energy. India is a major hub for outsourcing, offering a wide range of services to global industries including IT, finance, and customer support.